Loyola eCommons - Undergraduate Research and Engagement Symposium: Skin microbiota differs between Black and White patients with cutaneous T-cell lymphoma
 

Major

Biology

Anticipated Graduation Year

2025

Access Type

Open Access

Abstract

Cutaneous T-cell lymphoma (CTCL) disproportionately affects Black patients, who experience higher rates of sepsis and mortality. This study examines differences in the lesional and non-lesional skin microbiomes of Black and White CTCL patients using 16S rRNA and tuf gene sequencing. Results reveal distinct microbial compositions, with increased Staphylococcus aureus abundance in Black patients. Our team contributed by developing RStudio-based code to visualize and analyze microbiome sequencing data, facilitating clearer interpretation of microbial differences. These findings suggest microbial factors may contribute to racial disparities in CTCL outcomes, highlighting the need for targeted therapeutic interventions and further microbiome research.

Community Partners

Northwestern University Feinberg School of Medicine

Faculty Mentors & Instructors

Michael Burns - Associate Professor - Department of Biology

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Share

COinS
 

Skin microbiota differs between Black and White patients with cutaneous T-cell lymphoma

Cutaneous T-cell lymphoma (CTCL) disproportionately affects Black patients, who experience higher rates of sepsis and mortality. This study examines differences in the lesional and non-lesional skin microbiomes of Black and White CTCL patients using 16S rRNA and tuf gene sequencing. Results reveal distinct microbial compositions, with increased Staphylococcus aureus abundance in Black patients. Our team contributed by developing RStudio-based code to visualize and analyze microbiome sequencing data, facilitating clearer interpretation of microbial differences. These findings suggest microbial factors may contribute to racial disparities in CTCL outcomes, highlighting the need for targeted therapeutic interventions and further microbiome research.